Orion Portfolio Solutions’s iBio IBIO Stock Holding History

Orion Portfolio Solutions’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	2309
2020 Q1	$0	Buy	+1	New	+$385	﹤0.01%	2073

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Orion Portfolio Solutions's IBIO Position: Q2 2020 in Review

Orion Portfolio Solutions sold out of iBio (IBIO) in Q2 2020, closing a stake of 1 share.

Orion Portfolio Solutions first reported a position in IBIO in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 57 funds tracked by Wall St. Rank hold IBIO as of Q2 2020.

Orion Portfolio Solutions reported no remaining iBio position as of Q2 2020 after selling out during the quarter.
Orion Portfolio Solutions sold 1 iBio share in Q2 2020.
Orion Portfolio Solutions first reported a position in iBio in Q1 2020 and held it in 1 quarter.
Orion Portfolio Solutions's iBio position peaked at $0 in Q1 2020.
57 funds tracked by Wall St. Rank held iBio as of Q2 2020.

Based on Orion Portfolio Solutions's 13F filing for Q2 2020, filed 13 Aug 2020.